HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $52,016 | -28.2% | 34,448 | +18.9% | 0.00% | -100.0% |
| Q4 2022 | $72,403 | -46.4% | 28,961 | -10.1% | 0.00% | 0.0% |
| Q3 2022 | $135,000 | +75.3% | 32,232 | +16.4% | 0.00% | 0.0% |
| Q2 2022 | $77,000 | -48.7% | 27,680 | +5.7% | 0.00% | 0.0% |
| Q1 2022 | $150,000 | -37.0% | 26,177 | +0.5% | 0.00% | -50.0% |
| Q4 2021 | $238,000 | -15.6% | 26,057 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $282,000 | -23.0% | 26,351 | +11.6% | 0.00% | -33.3% |
| Q2 2021 | $366,000 | -10.1% | 23,602 | -6.1% | 0.00% | -25.0% |
| Q1 2021 | $407,000 | -23.2% | 25,126 | +0.4% | 0.00% | -20.0% |
| Q4 2020 | $530,000 | +37.7% | 25,031 | -3.7% | 0.01% | +25.0% |
| Q3 2020 | $385,000 | +35.6% | 25,982 | +34.6% | 0.00% | 0.0% |
| Q2 2020 | $284,000 | +20.3% | 19,309 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $236,000 | – | 20,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |